University of Arizona Cancer Center - Dignity Health ( Site 0062) — Phoenix, Arizona

University of Arizona Cancer Center - Dignity Health ( Site 0062) is a clinical research site located in Phoenix, Arizona, United States 85004.

Crixeo Clinical Trials Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Arizona Cancer Center - Dignity Health ( Site 0062) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Non-small Cell Lung Cancer.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Phoenix

Browse all research sites in Arizona · View every site in Phoenix

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Arizona Cancer Center - Dignity Health ( Site 0062)?

University of Arizona Cancer Center - Dignity Health ( Site 0062) has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Arizona Cancer Center - Dignity Health ( Site 0062) conducted?

University of Arizona Cancer Center - Dignity Health ( Site 0062) has 1 clinical trials on record, with 1 currently active. Their work covers Non-small Cell Lung Cancer.

Is University of Arizona Cancer Center - Dignity Health ( Site 0062) accredited by Crixeo Clinical Trials?

University of Arizona Cancer Center - Dignity Health ( Site 0062) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Arizona Cancer Center - Dignity Health ( Site 0062)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.